Neurocrine Biosciences Inc
NBIX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000914475
In the last 90 days, Neurocrine Biosciences Inc insiders filed 0 open-market purchases and 7 sales; 782 institutions reported holding it in 13F filings for Q2 2026, worth $17.0B in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Neurocrine Biosciences Inc as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 591
- +43 vs. Q4 2023
- Shares held
- 93.5M
- +1.24M (+1.3%) vs. Q4 2023
- Total value
- $12.9B
- +$736.9M (+6.1%) vs. Q4 2023
- New holders
- 92
- 226 more added
- Sold out
- 49
- 209 more reduced
7 institutions that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NBIX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 782 | $17.0B |
| Q1 2026 | 700 | $13.2B |
| Q4 2025 | 733 | $14.1B |
| Q3 2025 | 650 | $13.6B |
| Q2 2025 | 587 | $12.4B |
| Q1 2025 | 587 | $10.6B |
| Q4 2024 | 602 | $12.9B |
| Q3 2024 | 577 | $10.7B |
| Q2 2024 | 595 | $12.9B |
| Q1 2024 | 591 | $12.9B |
| Q4 2023 | 555 | $12.2B |
| Q3 2023 | 513 | $10.4B |
| Q2 2023 | 457 | $8.64B |
| Q1 2023 | 488 | $9.22B |
| Q4 2022 | 530 | $10.7B |
| Q3 2022 | 466 | $9.60B |
| Q2 2022 | 439 | $8.74B |
| Q1 2022 | 426 | $8.45B |
| Q4 2021 | 406 | $7.59B |
| Q3 2021 | 397 | $8.66B |
| Q2 2021 | 409 | $8.89B |
| Q1 2021 | 421 | $9.25B |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Neurocrine Biosciences Inc; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| ING Groep NV | 0 | $0 | 0.00% | −11,300−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Roman Butler Fullerton & Co | 0 | $0 | 0.00% | −8,837−100.0% | Sold out |
| TrimTabs Asset Management, LLC | 0 | $0 | 0.00% | −8,783−100.0% | Sold out |
| Raymond James Financial Services Advisors, Inc. | 0 | $0 | 0.00% | −8,201−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −7,339−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −7,180−100.0% | Sold out |
| Swiss Life Asset Management Ltd | 0 | $0 | 0.00% | −5,954−100.0% | Sold out |
| Cetera Advisor Networks LLC | 0 | $0 | 0.00% | −5,747−100.0% | Sold out |
| Ossiam | 0 | $0 | 0.00% | −5,376−100.0% | Sold out |
| Winton Group Ltd | 0 | $0 | 0.00% | −4,155−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −3,574−100.0% | Sold out |
| PEAK6 Investments LLC | 0 | $0 | 0.00% | −3,277−100.0% | Sold out |
| Camden Capital, LLC | 0 | $0 | 0.00% | −3,150−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −2,905−100.0% | Sold out |
| Curated Wealth Partners LLC | 0 | $0 | 0.00% | −2,841−100.0% | Sold out |
| American Trust | 0 | $0 | 0.00% | −2,680−100.0% | Sold out |
| Diversified Trust Co | 0 | $0 | 0.00% | −2,381−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −2,239−100.0% | Sold out |
| Capital Wealth Planning, LLC | 0 | $0 | 0.00% | −2,215−100.0% | Sold out |
| FDx Advisors, Inc. | 0 | $0 | 0.00% | −2,011−100.0% | Sold out |
| Allegheny Financial Group LTD | 0 | $0 | 0.00% | −1,698−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −1,088−100.0% | Sold out |
| Bank Julius Baer & Co. Ltd, Zurich | 0 | $0 | 0.00% | −1,084−100.0% | Sold out |
| C M Bidwell & Associates Ltd | 0 | $0 | 0.00% | −894−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −749−100.0% | Sold out |
| Kapitalo Investimentos Ltda | 0 | $0 | 0.00% | −503−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| EdgeRock Capital LLC | 0 | $0 | 0.00% | −217−100.0% | Sold out |
| Altshuler Shaham Ltd | 0 | $0 | 0.00% | −153−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −152−100.0% | Sold out |
| Lee Financial Co | 0 | $0 | 0.00% | −150−100.0% | Sold out |
| West Tower Group, LLC | 0 | $0 | 0.00% | −114−100.0% | Sold out |
| Point72 Europe (London) LLP | 0 | $0 | 0.00% | −87−100.0% | Sold out |
| Cape Investment Advisory, Inc. | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Able Wealth Management LLC | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| Chilton Capital Management LLC | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Psagot Value Holdings Ltd. / (Israel) | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Tfo-TDC, LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Aware Super Pty Ltd as trustee of Aware Super | – | – | – | – | Not filed |
| M&G Investment Management Ltd | – | – | – | – | Not filed |
| Putnam Investments LLC | – | – | – | – | Not filed |
| AtonRa Partners | – | – | – | – | Not filed |
| Desjardins Global Asset Management Inc. | – | – | – | – | Not filed |
| Coppell Advisory Solutions LLC | – | – | – | – | Not filed |
| Fairfield Financial Advisors, LTD | – | – | – | – | Not filed |